Navigation Links
Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR
Date:2/26/2009

DALLAS, Feb. 26 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.

Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m

Today's Trade Alerts include: Forest Laboratories Inc. (NYSE: FRX), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), Allergan Inc. (NYSE: AGN), Cephalon Inc. (Nasdaq: CEPH), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and Adolor Corp. (Nasdaq: ADLR).

Join the fastest growing investment community at: http://www.stockhideout.com

See what Cramer has to say about these stocks at: http://maddmoney.net/

BeaconEquity.com's Trade Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquity.com/m

BeaconEquity.com is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com/m CRD# 2207572.

BeaconEquity.com Disclosure

BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a wholly owned entity of BlueWave Advisors LLC, a financial public relations firm. Please read our report and visit our Web site, BeaconEquity.com, for complete risks and disclosures.

    Beacon Equity Research
    Jeff Bishop, (469)-252-3505
    press@beaconequity.com

David C. Masson of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2207572.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

JEFF BISHOP

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781


'/>"/>
SOURCE BeaconEquity.com
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioMagnetics Diagnostics Corp. Rated Speculative Buy, Target Price $1.42 by Beacon Equity Research
2. BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
3. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
4. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
5. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
6. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
7. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
8. Luminex Corporation to Present at ThinkEquity Partners Investor Conference
9. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
10. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
11. Dendreon Secures $130 Million Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... ... October 06, 2017 , ... With ... microscopy and surface analysis, Nanoscience Instruments is now expanding into Analytical Services. ... range of contract analysis services for advanced applications. Services will leverage techniques ...
(Date:10/7/2017)... 2017  The 2017 Nobel Prize in Chemistry ... Dubochet, Joachim Frank and Richard ... microscopy (cryo-EM) have helped to broaden the ... community. The winners worked with systems manufactured by ... highly resolved, three-dimensional images of protein structures that ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma ... Cancer Institute. The event is free and open to the public, but registration ...
(Date:10/5/2017)... ... October 05, 2017 , ... Understanding the microbiome, the ... in human health. Gut Love: You Are My Future, the newest exhibit on display ... as it explores the human condition through the lens of the gut microbiome. ...
Breaking Biology Technology:
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):